Clinical Resources
Materials for Providers
Alphabetical by Title
Standing orders for Administering Measles, Mumps, and Rubella Vaccine to Adults
Eligible healthcare professionals may vaccinate adults who meet any of the criteria on this form
Ask the Experts
CDC · FDA · State
ACIP Recommendations
Current Recommendations
Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices—United States, 2022
MMWR, November 18, 2022, 71 (46); 1465-1470
Interim Infection Prevention and Control Recommendations for Measles in Healthcare Settings
(Not an ACIP statement but an important document from CDC.)
CDC Infection Control Guideline Library – July 2019
Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 — Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, June 14, 2013; 62(RR04):1-34
Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine–Recommendations of the Advisory Committee on Immunization Practices
MMWR, May 7, 2010; 59(RR–3):1 – 16
CDC Recommended Schedules
FDA Package Inserts & EUAs
Measles, Mumps, Rubella: MMR II Package Insert
Merck & Co., Inc.
Measles, Mumps, Rubella: Priorix Package Insert
GSK
Combination Vaccine: ProQuad Package Insert
Merck & Co.
State Policies
U.S. map of MMR requirements